Position in AMRX
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$3,453,078
-$1,483,236 QoQ
Shares Held
277,802
-29.1% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SEGALL BRYANT & HAMILL, LLC holds $48,800,443 across 13 Drug Manufacturers - Specialty & Generic names. AMRX ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
585,769 | $20,712,791 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
56,934 | $7,500,485 | |
| 3 | PAHC |
Phibro Animal Health Corp
|
104,301 | $5,768,888 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
277,802 | $3,453,078 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
34,834 | $2,678,734 | |
| 6 | LQDA |
Liquidia Corp
|
55,938 | $2,111,100 | |
| 7 | SIGA |
Siga Technologies Inc
|
273,522 | $1,463,342 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
23,169 | $1,197,605 |
All Filings in AMRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,453,078 | 277,802 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $4,936,314 | 391,771 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,961,587 | 395,763 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,400,170 | 420,293 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,850,140 | 459,444 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,725,259 | 470,361 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,069,827 | 489,162 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,057,531 | 481,501 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||